Recurrent group A Streptococcus tonsillitis is an immunosusceptibility disease involving antibody deficiency and aberrant TFH cells.
Jennifer M DanColin Havenar-DaughtonKayla KendricRita Al-KollaKirti KaushikSandy L RosalesEricka L AndersonChristopher N LaRockPandurangan VijayanandGrégory SeumoisDavid LayfieldRamsey I CutressChristian Hermann OttensmeierCecilia S Lindestam ArlehamnAlessandro SetteVictor NizetMarcella BothwellMatthew BriggerShane CrottyPublished in: Science translational medicine (2020)
"Strep throat" is highly prevalent among children, yet it is unknown why only some children develop recurrent tonsillitis (RT), a common indication for tonsillectomy. To gain insights into this classic childhood disease, we performed phenotypic, genotypic, and functional studies on pediatric group A Streptococcus (GAS) RT and non-RT tonsils from two independent cohorts. GAS RT tonsils had smaller germinal centers, with an underrepresentation of GAS-specific CD4+ germinal center T follicular helper (GC-TFH) cells. RT children exhibited reduced antibody responses to an important GAS virulence factor, streptococcal pyrogenic exotoxin A (SpeA). Risk and protective human leukocyte antigen (HLA) class II alleles for RT were identified. Lastly, SpeA induced granzyme B production in GC-TFH cells from RT tonsils with the capacity to kill B cells and the potential to hobble the germinal center response. These observations suggest that RT is a multifactorial disease and that contributors to RT susceptibility include HLA class II differences, aberrant SpeA-activated GC-TFH cells, and lower SpeA antibody titers.
Keyphrases
- induced apoptosis
- young adults
- cell cycle arrest
- escherichia coli
- room temperature
- biofilm formation
- pseudomonas aeruginosa
- staphylococcus aureus
- cell death
- cystic fibrosis
- risk assessment
- regulatory t cells
- candida albicans
- dendritic cells
- antimicrobial resistance
- replacement therapy
- human health
- ionic liquid
- induced pluripotent stem cells
- smoking cessation